- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 28th, 2007
On the downside, shares in Oxonica fell 16-1/2 to 117-1/2 after the nanotechnology group said initial results from the second data point of 30,000 km of the fuel-borne nanocatalyst Envirox track trial - being carried out in Turkey on Turkish high-sulphur diesel fuel - are currently 'inconclusive'.
Following the news, Panmure Gordon downgraded its stance to 'hold' from 'buy' and cut its target price to 115 pence from 200. The broker also lowered revenue estimates for 2007 and 2008 by 42 pct and 56 pct respectively.
|Related News Press|
PEN Inc. Announces 1-for-180 Reverse Stock Split January 27th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells February 9th, 2016
Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016
From allergens to anodes: Pollen derived battery electrodes February 8th, 2016
Canadian physicists discover new properties of superconductivity February 8th, 2016
Host-guest nanowires for efficient water splitting and solar energy storage February 7th, 2016